High-dose haloperidol increases CSF opioid activity in patients with chronic schizophrenia

R. Rimon, L. Terenius, I. Averbuch, R. H. Belmaker

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Concentrations of Fraction I and II endorphins in CSF and serum and CSF haloperidol levels were determined in 12 patients with therapy-resistant chronic schizophrenia during high-dose haloperidol medication. After increasing the haloperidol dose from 60 mg to 120 mg daily a tendency for an increase of CSF Fraction I endorphin level was observed (t = 1.65 p > 0.05). In addition, there was a trend for a parallel increase of CSF Fraction I endorphin and serum and CSF haloperidol levels although the correlations did not reach statistical significance.

Original languageEnglish
Pages (from-to)9-12
Number of pages4
JournalPharmacopsychiatria
Volume6
Issue number1
DOIs
StatePublished - 1 Jan 1983
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'High-dose haloperidol increases CSF opioid activity in patients with chronic schizophrenia'. Together they form a unique fingerprint.

Cite this